,118 Clinical trials and meta-analyses suggest that cholinesterase inhibitors, particularly donepezil, may be beneficial in combating CVD due to their anti-inflammatory properties and their ability to increase ACh levels in the heart, as observed in Alzheimer’s disease and dementia patients with CVD.119. This evidence concerns the gene BCHE and Alzheimer disease.